Page last updated: 2024-10-31

nafoxidine and Glioma

nafoxidine has been researched along with Glioma in 1 studies

Nafoxidine: An estrogen antagonist that has been used in the treatment of breast cancer.

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yaz, G1
Kabadere, S1
Oztopçu, P1
Durmaz, R1
Uyar, R1

Other Studies

1 other study available for nafoxidine and Glioma

ArticleYear
Comparison of the antiproliferative properties of antiestrogenic drugs (nafoxidine and clomiphene) on glioma cells in vitro.
    American journal of clinical oncology, 2004, Volume: 27, Issue:4

    Topics: Animals; Antineoplastic Agents, Hormonal; Cell Division; Cell Line, Tumor; Cell Survival; Clomiphene

2004